[Clinical evaluation of combined treatment of stage III(B) Hodgkin's disease]
- PMID: 17168360
[Clinical evaluation of combined treatment of stage III(B) Hodgkin's disease]
Abstract
Patients with stage III Hodgkin's disease (110) received 2-3 courses of combination chemotherapy followed by total or subtotal irradiation, or exposure of primarily involved lymph nodes. The study did not include patients with persistent symptoms of intoxication. Overall 5- and 10-year survival rates were 78 and 68%, recurrence-free--75 and 74% respectively.
Similar articles
-
[Clinical evaluation of efficacy of chemoradiotherapy for Hodgkin's disease].Vopr Onkol. 2004;50(6):652-7. Vopr Onkol. 2004. PMID: 15755057 Russian.
-
[Is irradiation of intact ileoinguinal lymph nodes necessary in radiochemotherapy for stage-III Hodgkin's disease?].Vopr Onkol. 2007;53(4):453-5. Vopr Onkol. 2007. PMID: 17969410 Russian.
-
[Can extended induction chemoradiotherapy be effective in the combined treatment of stage IIIB Hodgkin's disease ?].Vopr Onkol. 2009;55(5):562-5. Vopr Onkol. 2009. PMID: 20020650 Russian.
-
[Primary treatment of early stage Hodgkin's disease].Orv Hetil. 2005 Jan 9;146(2):57-61. Orv Hetil. 2005. PMID: 15724953 Review. Hungarian.
-
New strategies for the treatment of early stages of Hodgkin's lymphoma.Hematol Oncol Clin North Am. 2007 Oct;21(5):871-80. doi: 10.1016/j.hoc.2007.06.014. Hematol Oncol Clin North Am. 2007. PMID: 17908625 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical